Imaging, Digital, Angiography Symposium 1

Related

• 

  Long-term Clinical Impact of Intravitreal anti-VEGF Therapy for Severe Non-proliferative Diabetic Retinopathy (NPDR): Analyses Through a Discrete Event Simulation Model

  Jennifer I. Lim, MD, FARVO, FASRS

  Updates from the Field

  2021

• 

  Real-world U.S. outcomes of anti-VEGF therapy in diabetic macular edema

  Thomas A. Ciulla, MD, MBA, FASRS

  Updates from the Field

  2017

• 

  What Happens to Diabetic Retinopathy Severity Scores With Less Aggressive Treatment? A Post Hoc Analysis of the RISE and RIDE Open Label Extension Study

  Roger A. Goldberg, MD, MBA

  Updates from the Field

  2019